Pharma 67: Targeted Cancer Therapies - Precision, Pathways, and Resistance
This is a free preview of a paid episode. To hear more, visit drmanaankarray.substack.com
This episode explores pathway-targeted cancer therapies as the pharmacology of precision with consequences. Monoclonal antibodies, small-molecule kinase inhibitors, and pathway disruptors are designed to strike specific molecular drivers of malignancy-often with dramatic early responses. We unpack oncogenic signalling, addiction to pathways, and biomark…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.